Professional Role and Responsibilities
John Mansueti, MD serves as the Executive Medical Director of Cancer Services at TidalHealth’s Richard A. Henson Cancer Institute and Allen Cancer Center. He also holds the position of Director of Radiation Oncology within TidalHealth’s hospital-based radiation oncology clinic, which serves the Delmarva Peninsula, including the Salisbury and Berlin, Maryland regions. His leadership role encompasses overseeing cancer care delivery, driving clinical excellence, and facilitating integration of advanced oncology technologies within the health system.
Clinical and Specialty Focus
Dr. Mansueti is a board-certified radiation oncologist, with a particular clinical interest in head and neck cancers, lung cancers, and other solid tumors. He completed his residency in Radiation Oncology through the National Capital Consortium, where he served as Chief Resident and Clinical Chief of radiation oncology. He is affiliated with both TidalHealth Peninsula Regional and Atlantic General Hospital, indicating an active clinical practice across multiple facilities within the health system’s network.
Education and Medical Training
- Medical Degree: Uniformed Services University of the Health Sciences (USUHS), F. Edward Hebert School of Medicine (1995–1999)
- Internship: National Naval Medical Center, Bethesda, MD (2000)
- Residency: Radiation Oncology at National Capital Consortium, served as Chief Resident
- Additional training includes attending the U.S. Naval Flight Surgeon School in Pensacola, Florida.
- Prior to his medical career, Dr. Mansueti graduated from the United States Naval Academy, ranking in the top 10% of his class, and served as a naval aviator for nine years.
Research and Clinical Trials Involvement
Dr. Mansueti has contributed to clinical research in radiation oncology, with a record of six research publications garnering over 70 citations. His research includes studies on long-term outcomes and toxicities of chemoradiation therapies. He is involved in advanced clinical trials at TidalHealth, including those using genomic risk scores (e.g., Decipher risk score) to guide prostate cancer therapy and trials evaluating stereotactic body radiation therapy (SBRT) in combination with conventional radiation treatments.
Professional Achievements and Recognitions
- Dr. Mansueti has been recognized as an award-winning practitioner within the TidalHealth system and recipient of five hospital awards related to quality and healthcare excellence.
- He has been profiled and featured in multiple TidalHealth communications and podcasts, highlighting his role in community cancer services and patient education on the importance of early screenings and preventive care.
- His leadership contributed to TidalHealth's recent national accreditation by the American College of Surgeons (ACS) Commission on Cancer (CoC), reflecting the program’s advancement under his direction.
- Named in Metropolitan Magazine’s “Best in Healthcare 2024”, emphasizing his standing in the regional medical community.
Community and Patient Engagement
Dr. Mansueti actively participates in local health education efforts, including podcasts and public awareness campaigns promoting cancer prevention, screening, and innovative treatment options. TidalHealth has highlighted his commitment to patient-centered care and the integration of cutting-edge cancer technology aimed at reducing patient treatment time and side effects.
Technology and Innovation Leadership
Under Dr. Mansueti’s executive direction, TidalHealth’s cancer program has implemented new cancer care technologies at its Allen Cancer Center, which focus on improving treatment outcomes and patient experience. This includes initiatives to introduce less painful and more efficient radiation therapy techniques, supporting TidalHealth’s strategy to enhance oncology services across the Delmarva Peninsula.
This detailed profile situates Dr. John Mansueti as a highly experienced and influential radiation oncologist and cancer services leader within TidalHealth. His combination of clinical expertise, military discipline, research involvement, and executive oversight positions him at the forefront of regional oncology care delivery and innovation.
